Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Hand-Hygiene Compliance is Low Amongst Emergency Medical Workers

Studies show paramedic workers ignored World Health Organization guidelines when soap and water or antiseptic rub was needed. 1 The University of Southern Denmark in Odense studied 77 paramedics in Finland, Sweden, Denmark, and Australia as they treated 87 patients. The study found that hand hygiene compliance among EMS providers is “remarkably low,” with an “over-reliance” on…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

Studies show paramedic workers ignored World Health Organization guidelines when soap and water or antiseptic rub was needed. 1 The University of Southern Denmark in Odense studied 77 paramedics in Finland, Sweden, Denmark, and Australia as they treated 87 patients. The study found that hand hygiene compliance among EMS providers is “remarkably low,” with an “over-reliance” on gloves and a “tendency toward self-protection instead of patient protection.”2 They found that only 3% of emergency medical personnel used either hand-wash or hand sanitizers before patient contact. Gloves were worn in 54% of all hand hygiene indications. Researchers said that while the paramedics complied with basic hygiene at a high rate, many ignored World Health Organization guidelines in instances where soap and water or antiseptic rub was needed.

A Worldwide Problem

Hand hygiene compliance isn’t just a problem that’s isolated to Europe either. A study published in the American Journal of Infection Control (AJIC), tracked hygienic practices at hospitals in the United States and found disturbingly similar results.3 In this study, all participants believed they were fully compliant, and yet, less than half used proper hand-washing techniques, and just over a third wore gloves. And unfortunately, far too many of those in the study believed gloves were enough protection. However, researchers were keen to point out that proper hand-washing and gloves are both crucial to preventing infections spreading from either party. According to the AJIC study, “Hand hygiene and glove use are highly intertwined in clinical practice and should be considered jointly in infection prevention improvement efforts.”

Knowing the Proper Procedure

When 1 in 31 hospital patients has an infection resulting from the healthcare they received, increased vigilance must be taken to ensure that EMS providers are complying with CDC guidelines for hand hygiene.4 The CDC recommends washing your hands with either alcohol-based sanitizers or antiseptic soaps both before and after eating, having contact with a patient’s skin or fluids, and touching inanimate surfaces near the patient. Additionally, hand-washing is vital after using the restroom, and especially after taking off gloves. Gloves are critical to proper hand hygiene in patient care, but all hygienic measures must be taken to ensure across-the-board safety.

AliMed has a wide selection of products to help prevent infection with solutions for every setting. To learn more about our infection control products visit https://www.alimed.com/infection-control/

References

  1. Vikke HS, Vittinghus S, Giebner M, et al Compliance with hand hygiene in emergency medical services: an international observational study Emerg Med J 2019;36:171-175.
  2. Vikke HS, Vittinghus S, Giebner M, et al Compliance with hand hygiene in emergency medical services: an international observational study Emerg Med J 2019;36:171-175.
  3. https://www.ajicjournal.org/article/S0196-6553(18)31107-6/fulltext
  4. https://www.cdc.gov/handhygiene/index.html

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus’ $450M Alkeus deal puts phase 3 retina programs on the same integration plan

Tarsus has made a $450 million deal with Alkeus to acquire two assets, including a phase 3 oral Stargardt program and a post-injection antiseptic. The focus now moves to clinical trial operations, chemistry manufacturing and controls, and plans for specialty distribution. These acquisitions aim to expand Tarsus' retina programs.

  • 01Tarsus acquired a phase 3 oral Stargardt asset and a post-injection antiseptic for $450 million.
  • 02The acquisitions focus on enhancing clinical trial operations and chemistry manufacturing controls.
  • 03Plans for future specialty distribution of the acquired assets are in place.

Aug 29, 2026

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

FDA’s Oct. 19 AI docket forces medtech teams to write tests, not slide decks

The FDA has released a generative AI discussion paper proposing a shift towards competency-style evaluation and increased postmarket monitoring in the healthcare industry. This move may lead vendors and hospital buyers to prioritize developing robust testing protocols for AI applications. The focus is on ensuring reliable and safe AI implementation in medical technologies.

  • 01The FDA's discussion paper suggests implementing competency-style evaluation for AI in healthcare.
  • 02There is an emphasis on increased postmarket monitoring for AI applications in the medical field.
  • 03Vendors and hospital buyers are encouraged to focus on developing testing protocols rather than presentations.

Aug 29, 2026

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 brings smart glasses and AI into the purchasing cycle

SILMO Paris 2026 is focusing on integrating smart glasses and AI into the purchasing processes for optical retailers and labs. The event is anticipated to attract around 34,000 visitors and feature 950 exhibitors, indicating significant interest in AI imaging workflows and smart-glass innovations. The agenda highlights a future direction towards advanced technology in optical retail and laboratory settings.

  • 01SILMO Paris 2026 will host nearly 34,000 visitors and 950 exhibitors.
  • 02The event focuses on AI imaging workflows and smart-glass innovations for optical retailers and labs.
  • 03Significant interest is shown in integrating advanced technology within optical retail processes.

Aug 29, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512